Johansson Martin L, Calon Tim G A, Omar Omar, Shah Furqan A, Trobos Margarita, Thomsen Peter, Stokroos Robert J, Palmquist Anders
Department of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Research and Technology, Oticon Medical AB, Askim, Sweden.
Front Cell Infect Microbiol. 2021 Mar 30;11:640899. doi: 10.3389/fcimb.2021.640899. eCollection 2021.
Osseointegration is a well-established concept used in applications including the percutaneous Bone-Anchored Hearing System (BAHS) and auricular rehabilitation. To date, few retrieved implants have been described. A systematic review including cases where percutaneous bone-anchored implants inserted in the temporal bone were retrieved and analyzed was performed. We also present the case of a patient who received a BAHS for mixed hearing loss. After the initial surgery, several episodes of soft tissue inflammation accompanied by pain were observed, leading to elective abutment removal 14 months post-surgery. Two years post-implantation, the implant was removed due to pain and subjected to a multiscale and multimodal analysis: microbial DNA using molecular fingerprinting, gene expression using quantitative real-time polymerase chain reaction (qPCR), X-ray microcomputed tomography (micro-CT), histology, histomorphometry, backscattered scanning electron microscopy (BSE-SEM), Raman spectroscopy, and fluorescence hybridization (FISH). Evidence of osseointegration was provided micro-CT, histology, BSE-SEM, and Raman spectroscopy. Polymicrobial colonization in the periabutment area and on the implant, including that with and , was determined using a molecular analysis a 16S-23S rDNA interspace [IS]-region-based profiling method (IS-Pro). The histology suggested bacterial colonization in the skin and in the peri-implant bone. FISH confirmed the localization of and coagulase-negative staphylococci in the skin. Ten articles (54 implants, 47 patients) met the inclusion criteria for the literature search. The analyzed samples were either BAHS (35 implants) or bone-anchored aural epitheses (19 implants) between 2 weeks and 8 years. The main reasons for elective removal were nonuse/changes in treatment, pain, or skin reactions. Most samples were evaluated using histology, demonstrating osseointegration, but with the absence of bone under the implants' proximal flange. Taken together, the literature and this case report show clear evidence of osseointegration, despite prominent complications. Nevertheless, despite implant osseointegration, chronic pain related to the BAHS may be associated with a chronic bacterial infection and raised inflammatory response in the absence of macroscopic signs of infection. It is suggested that a multimodal analysis of peri-implant health provides possibilities for device improvements and to guide diagnostic and therapeutic strategies to alleviate the impact of complications.
骨整合是一个已确立的概念,应用于包括经皮骨锚式听力系统(BAHS)和耳廓重建等领域。迄今为止,关于取出植入物的描述很少。我们进行了一项系统综述,纳入了颞骨中植入的经皮骨锚式植入物取出并分析的病例。我们还报告了一例因混合性听力损失接受BAHS的患者。初次手术后,观察到几次伴有疼痛的软组织炎症发作,导致在术后14个月择期取出基台。植入两年后,因疼痛取出植入物,并对其进行多尺度和多模态分析:使用分子指纹技术分析微生物DNA,使用定量实时聚合酶链反应(qPCR)分析基因表达,使用X射线显微计算机断层扫描(micro-CT)、组织学、组织形态计量学、背散射扫描电子显微镜(BSE-SEM)、拉曼光谱和荧光原位杂交(FISH)。micro-CT、组织学、BSE-SEM和拉曼光谱提供了骨整合的证据。使用基于16S-23S rDNA间隔区[IS]的分析方法(IS-Pro)通过分子分析确定了基台周围区域和植入物上的多微生物定植,包括金黄色葡萄球菌和凝固酶阴性葡萄球菌。组织学提示皮肤和植入物周围骨中有细菌定植。FISH证实了金黄色葡萄球菌和凝固酶阴性葡萄球菌在皮肤中的定位。十篇文章(54个植入物,47名患者)符合文献检索的纳入标准。分析的样本为BAHS(35个植入物)或骨锚式耳假体(19个植入物),时间跨度为2周至8年。择期取出的主要原因是不使用/治疗方案改变、疼痛或皮肤反应。大多数样本通过组织学评估,显示骨整合,但植入物近端凸缘下方无骨。综上所述,尽管有明显的并发症,但文献和本病例报告显示了骨整合的明确证据。然而,尽管植入物实现了骨整合,但与BAHS相关的慢性疼痛可能与慢性细菌感染以及在无宏观感染迹象的情况下炎症反应增强有关。建议对植入物周围健康状况进行多模态分析,为改进设备以及指导诊断和治疗策略以减轻并发症的影响提供可能性。